AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 1 filers reported holding AIMMUNE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $13,380,000 | +241.0% | 388,384 | +65.4% | 0.10% | +188.2% |
| Q2 2020 | $3,924,000 | -33.6% | 234,855 | -42.7% | 0.03% | -51.4% |
| Q1 2020 | $5,906,000 | -17.3% | 409,576 | +92.0% | 0.07% | +66.7% |
| Q4 2019 | $7,139,000 | -61.0% | 213,302 | -75.6% | 0.04% | -66.7% |
| Q3 2019 | $18,297,000 | +430.5% | 873,767 | +427.4% | 0.13% | +472.7% |
| Q2 2019 | $3,449,000 | +383.7% | 165,678 | +419.2% | 0.02% | +340.0% |
| Q1 2019 | $713,000 | -92.1% | 31,913 | -91.5% | 0.01% | -92.3% |
| Q4 2018 | $9,012,000 | -46.3% | 376,759 | -38.5% | 0.06% | -14.5% |
| Q3 2018 | $16,781,000 | +71.1% | 613,039 | +68.0% | 0.08% | +68.9% |
| Q2 2018 | $9,810,000 | -71.9% | 364,812 | -66.7% | 0.04% | -69.0% |
| Q1 2018 | $34,872,000 | – | 1,095,575 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|